SCHEMBL829864

SCHEMBL829864

OCC=CCCCCCCCCC=CCO

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.38
TRPV1 Q8NER1 1/20 0.38
TERT O14746 3/20 0.37
PTPN1 P18031 3/20 0.37
PPARG P37231 3/20 0.37
PPARD Q03181 3/20 0.37
PPARA Q07869 3/20 0.37
CYP1A2 P05177 2/20 0.37
MAPT P10636 2/20 0.37
CYP2C19 P33261 2/20 0.37
BLM P54132 2/20 0.37
HSD17B10 Q99714 2/20 0.37
FABP4 P15090 2/20 0.37
F7 P08709 2/20 0.37
F3 P13726 2/20 0.37
KMT2A Q03164 2/20 0.37
GMNN O75496 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14702360 1.00 FAAH (0.38) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL829863 1.00 FAAH (0.38) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL16220975 0.96 FAAH (0.33) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL7127824 0.96 FAAH (0.33) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL7127822 0.96 FAAH (0.33) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL7127803 0.91 LMNA (0.36) TRPV1TERTCYP1A2MAPTCYP2C19
SCHEMBL1010054 0.91 LMNA (0.36) TRPV1TERTCYP1A2MAPTCYP2C19
SCHEMBL1010055 0.91 LMNA (0.36) TRPV1TERTCYP1A2MAPTCYP2C19
SCHEMBL162597 0.91 LMNA (0.36) TRPV1TERTCYP1A2MAPTCYP2C19
SCHEMBL7127799 0.91 LMNA (0.36) TRPV1TERTCYP1A2MAPTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4704715-A2 BIOPSY SITE TISSUE REPAIR APPARATUS AND METHODS Burkett, Joseph Choate (US) 2026-03-11 EP claimed
WO-2024229303-A2 BIOPSY SITE TISSUE REPAIR APPARATUS AND METHODS BURKETT JOSEPH CHOATE (US) 2024-11-07 WO claimed
US-20220338982-A1 SYSTEM AND METHOD FOR IMPLANTING AND SECURING A BIOPROSTHETIC DEVICE TO WET TISSUE EDWARDS LIFESCIENCES CORPORATION 2022-10-27 US claimed
CN-110402122-B Systems and methods for implanting and securing bioprosthetic devices to wet tissue 爱德华兹生命科学公司 2022-08-16 CN claimed
US-11382738-B2 System and method for implanting and securing a bioprosthetic device to wet tissue EDWARDS LIFESCIENCES CORPORATION (US) 2022-07-12 US claimed
US-20090148945-A1 Novel Biodegradable Elastomeric Scaffold for Tissue Engineering and Light Scattering Fingerprinting Methods for Testing the Same NORTHWESTERN UNIVERSITY (US) 2009-06-11 US claimed
WO-2026104575-A1 COMPOSITION COMPRISING PRE-POLYMER TISSIUM SA (FR) 2026-05-21 WO disclosed
EP-4744896-A1 COMPOSITION COMPRISING PRE-POLYMER Tissium SA (FR) 2026-05-20 EP disclosed
US-12606670-B2 Composition comprising activated and functionalized prepolymer TISSIUM SA (FR) 2026-04-21 US disclosed
EP-4704715-A2 BIOPSY SITE TISSUE REPAIR APPARATUS AND METHODS Burkett, Joseph Choate (US) 2026-03-11 EP disclosed
EP-4698242-A1 COMPOSITION FOR USE IN TISSUE RECONSTRUCTION AND TISSUE REGROWTH Tissium SA (FR) 2026-02-25 EP disclosed
US-12496051-B2 Device for applying adhesive composition to biological tissue and/or prosthetic material TISSIUM (FR) 2025-12-16 US disclosed
EP-4656698-A2 COMPOSITION COMPRISING ACTIVATED AND FUNCTIONALIZED PREPOLYMER Tissium SA (FR) 2025-12-03 EP disclosed
EP-1973493-A2 BIODEGRADABLE ELASTOMERS Massachusetts Institute of Technology (US) 2008-10-01 EP disclosed
WO-2007082304-A2 BIODEGRADABLE ELASTOMERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2007-07-19 WO disclosed
WO-2007082305-A2 BIODEGRADABLE ELASTOMERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2007-07-19 WO disclosed
WO-2007038625-A2 BIODEGRADABLE NANOCOMPOSITES WITH ENHANCED MECHANICAL PROPERTIES FOR SOFT TISSUE ENGINEERING. NORTHWESTERN UNIVERSITY (US) 2007-04-05 WO disclosed
US-20070071790-A1 Biodegradable nanocomposites with enhance mechanical properties for soft tissue NORTHWESTERN UNIVERSITY (US) 2007-03-29 US disclosed
WO-2005028631-A2 A NOVEL BIODEGRADABLE ELASTOMERIC SCAFFOLD FOR TISSUE ENGINEERING AND LIGHT SCATTERING FINGERPRINTING METHODS FOR TESTING THE SAME NORTHWESTERN UNIVERSITY (US) 2005-03-31 WO disclosed
US-20050063939-A1 Polyester of citric acid and linear aliphatic diol, such as 1,8-octanediol; culturing cells on polyester substrate NORTHWESTERN UNIVERSITY (US) 2005-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12606670-B2 Composition comprising activated and functionalized prepolymer PAM, CUTA, DSP FAAH 730/4885TRPV1 841/4885TERT 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.